Lineage Cell Therapeutics, Inc. Deferred Costs
Lineage Cell Therapeutics, Inc. (LCTX) had Deferred Costs of $470.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCostsCurrentAndNoncurrent · last filed 2016-03-15
- 2015-12-31: Deferred Costs $470.00K.
- 2015-06-30: Deferred Costs $406.00K.
- 2015-03-31: Deferred Costs $418.96K.
- 2014-12-31: Deferred Costs $446.33K.
| Period end | Deferred Costs |
|---|---|
| 2015-12-31 | $470.00K 10-K · filed 2016-03-15 |
| 2015-06-30 | $406.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $418.96K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $446.33K 10-K · filed 2015-03-11 |
| 2014-03-31 | $528.46K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $555.83K 10-K · filed 2014-03-17 |
| 2013-09-30 | $566.71K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $594.08K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $621.46K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $648.83K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |